Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
stock up and just hold ..... waiting on news upset
I'm also loaded in BLOK - their BTC/ETH mining operation will be one of the largest, TINY float as well.
Will keep updating that board: https://investorshub.advfn.com/Block-One-Capital-Inc-TSXV-BLOK-32779/
Hope you all can join us.
Of course.
What a finish. I don’t like to get my hopes up though. But it looks good. Strong volume into the close a good sign.
in Toronto in the winter?
At this rate I’ll be buying a Lamborghini for Xmas :)
geezx...this thing's on fire...lol
Ty! Still a tiny float, glad we’ve got it now.
65 mil o\s @ 30.09.17 per the latest filing - pretty fugly but scroll to the bottom:
CALYX BIO-VENTURES INC.
CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(Unaudited – Expressed in Canadian Dollars)
The accompanying notes are an integral part of these condensed interim consolidated financial statements.
Capital Stock
Notes
Number
Amount
Subscriptions Received
Contributed Surplus
Deficit
Total
Balance as at December 31, 2015
50,618,673
6,832,163
-
2,325,193
(8,868,419)
288,937
Loss for the period
-
-
-
-
(59,680)
(59,680)
Balance as at September 30, 2016
50,618,673
6,832,163
8,500
2,325,193
(9,064,952)
100,904
Shares issued for cash
8
Balance as at December 31, 2016
61,384,529
7,680,624
-
2,570,076
(9,564,759)
685,941
Subscriptions received
8
-
-
117,000
-
-
117,000
Shares issued for intangible assets
6, 8
4,540,000
340,500
-
-
340,500
Loss for the period
-
-
-
-
(441,545)
(441,545)
Balance as at September 30, 2017
65,924,529
$ 8,021,124
$ 117,000
$ 2,570,076
$ (10,006,304)
$ 701,896
Yeah...here is the news release:
Calyx Commences Crypto Mining and Blockchain Validation Operations at Second Data Centre
November 30, 2017 – Vancouver, British Columbia - Calyx Bio-Ventures Inc. (TSXV: CYX) (“Calyx” or the “Company”) is pleased to announce that its wholly owned subsidiary Canada Blockchain Hosting Corp (“CBH”) a Vancouver based blockchain computing company has acquired and successfully completed the installation and setup of its first cryptocurrency mining and blockchain data validation operation in Kamloops, British Columbia.
This is the second phase of the Company’s objective to integrate a general cryptocurrency mining facility and distributed computing platform into the Company’s existing blockchain business model. This additional computing and hash power will allow CBH to immediately generate additional revenues and significantly enhance the Company’s ability to support the expansion of its private blockchain ecosystem.
This array of units is currently mining BTC, ETH, Decred, Lbry, Zcash, and Pascal, and will expand to cover any other cryptocurrency that may be profitable in the near term. A number of these currencies have seen significant appreciation in the last year.
The acquisition brings 50 high performance mining units, each with 7 GPUs, under CBH's ownership (with rights to acquire another 40 units immediately), which allows for quick expansion and buildout without waiting for new hardware from suppliers. The flexibility of GPU mining versus Asic based mining allows CBH to participate in mining pools which maximizes profitability regardless of the cryptocurrency being mined. All mining proceeds will be paid out in either BTC or ETH depending on profitability at the time.
In addition, the transaction gives CBH access to a second data centre location from which to operate and expand, which is occupied on attractive terms, including advantageous access to and pricing for power and cooling.
The next phase of the Company's cryptocurrency strategy is being built out in its new office headquarters, where the Company is installing 1000 square foot data centre space to accommodate approximately 100 13-GPU mining units, with a view to expanding that to a 7,500 square feet upon completion of negotiations with facility owners.
In consideration for the assets acquired and facility space, Calyx has paid $250,000.
“This is another significant step in the execution of the Company’s strategic plan originally announced in October to integrate next generation blockchain features and services into our commercial platforms” commented Roger Forde, President & Chief Executive Officer of the Company. “This first phase provides us with a testing ground to streamline our blockchain technology currently being developed for the cannabis e-commerce space, and will generate revenue today that will cover our underlying costs on a month-to-month basis. The Company
Legal*34240995.1
has sufficient cash in hand to accelerate that plan to the next phase and growth beyond that will
be based on opportunities that present themselves.”
About Calyx
Calyx operates through two wholly-owned subsidiaries. Cannigistics Agri-Solutions Corp is a
software development company that has created a software platform originally designed for
advanced indoor agriculture, but has now evolved to serve a wider range of industries. Canada
Blockchain Holdings Corp. is a company operating in blockchain technologies and crypto
currencies. Additionally, Calyx owns a portfolio of proprietary intellectual property with
applications in crop enhancement, as well as messaging software assets.
For further information about Calyx, please visit www.calyxbio.com or contact:
Roger Forde
President and Chief Executive Officer
Calyx Bio-Ventures Inc.
Tel: 604.880.8822
Email: rogerf@calyxbio.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is
defined in the policies of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
lol...at least now you can afford the good stuff...no more Two-Buck-Chuck
Insiders own quite a bit. I’ll get confirmation tonight. I drink too much wine at night :)
I thought I was 64 mil o\s on SEDAR? Can't remember
Yea man. I’ve been in this one since 10 cents. Super solid low float bitcoin mining company. I’ll update this board tonight. At $2/share it’s a 100 mill market cap which is realistic.
This thing's moving also...took a small piece
Mr. Forde continued, “although blockchain is very likely the most secure and best technology to utilize to eliminate potential discrepancies amongst disparate systems, problems arise when it becomes necessary to make critical updates, bug fixes, and upgrades. When a change must be made to the way a crypto currency works, the changes must be made very carefully to keep the new version of coins compatible with older coins. This can present a big problem to many when discrepancies leave two ledgers operating instead of one. This precise problem is referred to as a 'fork', and the panic that ensues when a crypto currency finds itself in such a situation is a big problem we now see emerging.”
“As such, we have taken careful measures to assess the latest in blockchain development as we grow and evolve our product offerings. We have identified a third generation blockchain technology that is being proven out by a specific group who we see as world leaders in the sector. This technology allows for complete technological evolution that can be implemented into the core ecosystem of the blockchain backbone without compromising the security, compatibility and historical accuracy of the blocks and ledgers.”
Calyx believes this latest blockchain evolution is so powerful, it opens the possibility of an 'open source' like development approach, where developers can submit code to a functioning blockchain ecosystem, and administrators or a governing community can decide whether or not to implement the new logic and remove the old logic, while not compromising the integrity of the ledgers and blocks. This eliminates the need for both planned and accidental forks.
Read more at http://www.stockhouse.com/companies/bullboard/v.cyx/calyx-bio-ventures-inc?postid=26947046#YcfeAVtZRaS328mQ.99
NEWS: CYX Completes $1 Million placement for blockchain! Solid news, now with $1 million cash on hand, this new blockchain play should surge. News released friday, it looks like it's waking up!
News:
VANCOUVER, British Columbia, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Calyx Bio-Ventures Inc. (TSX-V:CYX) (“Calyx” or the “Company”) is pleased to announce that it has completed a non-brokered private placement of 14,857,143 units (each, a “Unit”), at a price of $0.07 per Unit, for gross proceeds of $1,040,000. Each Unit consists one common share of the Company, and one-half-of-one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant is exercisable to acquire one additional common share of the Company at a price of $0.15 per share for a period of twenty-four months.
All securities issued in connection with the private placement are subject to a four-month-and- one-day statutory hold period expiring on March 11th, 2018. In connection with closing of the private placement, the Company paid a cash commission of $2,100.
The Company is also pleased to announce that it has entered into a letter of intent to lease and build out an additional facility that will house the Company’s new corporate head office and a “state of the art” environment to execute on its strategic plan to deploy its first data mining facility and to provide additional space to better support operations and ongoing business development.
Quite the churn on friday, big news. I'll update this board and make it pretty.
Calyx (TSXV: CYX) Provides Corporate Update and Cancels Private Placement Financing
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 9, 2014) - Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx" or the "Company") announces that it has entered into an agreement with BDC Capital Inc. and Agrisoma Biosciences Inc. ("Agrisoma") pursuant to which Calyx has agreed to waive its pre-emptive right in order to allow a third party to finance Agrisoma. The proposed Agrisoma financing, if it were to proceed as proposed and without Calyx's participation will, upon closing, dilute Calyx's interest in Agrisoma from 49.96% to approximately 29%. Following an evaluation by an Independent Committee of Calyx's board of directors, it was determined that in Calyx's view, Agrisoma's business had not progressed as expected, and no options for financing Agrisoma could be found that would be satisfactory to shareholders of Calyx.
Additionally, intellectual property ("IP") which was exclusively licensed to Agrisoma by Calyx is no longer under exclusive license to Agrisoma. With the IP reverting to Calyx, Calyx is now able to license and utilize its IP in other agricultural sector opportunities that it is currently investigating. The unique and powerful features of this technology provide clear advantages for the development of plant-based products. Calyx is in discussions and pursuing a number of new business opportunities in the agriculture and agri-pharmaceutical sectors including the MMPR (Marijuana for Medical Purposes Regulations) and marijuana biotech where we can bring our depth of agriculture capacities.
Accordingly, the Calyx board has determined to cancel the dilutive non-brokered private placement for the issuance of up to 35 million units at a price of six cents per unit for cash proceeds of up to $2.1-million previously announced on March 31, 2014.
About Calyx
Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is an agricultural technology company which is developing early stage agriculture ventures. Calyx brings its depth of experience, capital and other capacity, including its proprietary intellectual property, to enhance plant yields. In addition to Calyx's shareholding in Agrisoma Biosciences Inc., a company which is producing a non-food energy feedstock crop for bioenergy, Calyx is pursuing agri-pharmaceutical opportunities in the MMPR (Marijuana for Medical Purposes Regulations) and the agri-tech space. The medical marijuana industry is in its infancy and is an emerging multibillion-dollar opportunity undergoing significant regulatory and legal reform which offers strong growth opportunities to early participants. For further information about Calyx, please visit www.calyxbio.com
Scientific Study Reveals ReadiDiesel® Meets Petroleum-Based Diesel Specifications Without Blending Fossil Fuels
Source: http://bit.ly/19kX881
June 24, 2013 – Vancouver, British Columbia – Calyx Bio-Ventures Inc. (TSX-V: CYX) is
pleased to announce that Resonance® energy feedstock provided by Calyx subsidiary Agrisoma Biosciences, was found to be the most similar to petroleum-derived fuels as compared to other renewable fuels tested in a recent study conducted by the Coordinating Research Council (CRC), a non-profit organization that encourages, promotes and studies various fuels through scientific research.
The study, Advanced Alternative and Renewable Diesel Fuels: Detailed Characterization of
Physical and Chemical Properties, confirmed that ReadiDiesel®, made from Agrisoma’s
Resonance™ energy cairnata feedstock, “looked more like the petroleum-derived fuels than the
other renewable fuels…” The study compared the results of detailed analyses of the physical and chemical properties of 10 advanced alternative and renewable diesel fuels and four commercial ultra low sulfur diesels.
A key objective of the blind study was to identify the similarities and differences of alternative
and renewable fuels as compared to conventional petroleum derived diesel fuels. Samples were
obtained from select manufacturers who produced diesel on a relatively large scale (from pilot to
commercial scale) and agreed to participate in the study.
Highlights of the report include:
• Referring to RD3 (ReadiDiesel): “…looked more like the petroleum-derived fuels than
the other renewable fuels…” Page xviii, Executive Summary.
• ReadiDiesel was the only fuel tested that had the same level of aromatics as petroleumbased diesel fuel, the main reason most alternative fuels require blending with petroleum.
ReadiDiesel, made by Applied Research Associates (ARA) and Chevron Lummus Global from
Agrisoma Resonance® energy feedstock, is referred to as "RD3" in the report the report.
“The CRC report provides a broad view and comprehensive analysis of the slate of alternative
and renewable diesel fuels at or near commercial scale. Our ReadiDiesel, made from Agrisoma’s Resonance energy feedstock, clearly stands out, meeting D975 specs without blending and having a molecular makeup that is almost indistinguishable from the ultra low sulfur diesels tested in the program,” said Ed Coppola, ARA Fuels Technical Lead.
“The fact that ReadiDiesel has a density equivalent to petroleum diesels is significant from an
operational perspective as it equates to extra miles per gallon for a diesel fleet,” said Chuck Red,
ARA’s Vice President, Fuels Development.
“The CRC study is one more confirmation that Resonance® carinata can be used as a feedstock
for fuels that are complete petroleum substitutes, resulting in substantially reduced carbon and
other harmful emissions without compromising performance,” said Hugh Notman, president and
CEO of Calyx. “This further supports our efforts to become a leading non-food source of
biofuels that can be utilized seamlessly in petroleum-fuel powered engines, whether they be in
planes, ground transportation or other applications.”
Access to the full CRC Report visit http://www.crcao.org/reports/recentstudies2013/AVFL-19-
2/CRC%20Project%20AVFL-19-2%20Final%20Report.pdf
The AVFL-19 Working Group (of the CRC) is comprised of representatives from energy
companies, U.S. national labs, and a Canadian national lab. The time and testing expenses of the authors were largely funded by their respective organizations. Members of the U.S. Department of Energy National Laboratories used funding from their budgets provided by U.S. DOE Vehicle Technologies Program. Members of National Resources Canada and Canmet ENERGY used funding from their budgets provided by the Government of Canada’s interdepartmental Program of Energy Research and Development, PERD 113 Petroleum Conversion for Cleaner Air.
Calyx (CYX.V) Majority-Owned Subsidiary, Agrisoma Biosciences Inc., Enters Into Marketing and Distribution Agreement With Subsidiary of Paterson Grain
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 3, 2013) -Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is pleased to announce that its majority-owned subsidiary, Agrisoma Biosciences Inc. ("Agrisoma") and PGF Biofuels Inc. ("PGF") have entered into a long term strategic agreement for marketing and distribution.
PGF is a wholly owned subsidiary of Paterson GlobalFoods Inc. ("Paterson"), owner of Paterson Grain. Paterson is a private family-owned group of companies active in Europe, Asia, Australia, and the Americas. Founded in 1908 and headquartered in Winnipeg, Manitoba, Paterson operates approximately 40 grain handling sites across the Canadian prairies, including nine inland export terminals.
The new long-term agreement appoints PGF as Agrisoma's exclusive partner for Resonance® carinata, a non-food oilseed crop, in North America and Australia, and establishes a framework through which PGF and Agrisoma will coordinate expansion into additional regions. Under the original agreement in 2012, Paterson was the exclusive contracting partner for the production of Resonance® in Western Canada.
Paterson played a key role in the commercial production launch of Resonance® in 2012, acting as the contracting partner for 6,000 acres planted and harvested last year at approximately 40 farms in Saskatchewan and Alberta. Fifty acres were planted in 2011. Under the new agreement Paterson will manage the purchase of Resonance® carinata production from growers and the subsequent processing and sale of product. Agrisoma will be paid a royalty on sales generated from Resonance® carinata, which will vary depending on the nature of the end products sold.
Hugh Notman, president and CEO of Calyx, said, "The agreement is vital to building the value chain from seed through to product sales. Our focus now turns to ramping up carinata production in the coming years."
"Building a strong partnership between Agrisoma and Paterson strengthens our goals to cover a much broader geographical region," said Dr. Steven Fabijanski, president and CEO of Agrisoma. "As we expand the production of Resonance® carinata, there isn't a better company to work with than Paterson. They have been at the forefront of the grain handling business for more than a century and are leaders in seed sales, relationships with farmers, logistics, transportation, elevation and the sale of grain."
"We are pleased to expand our relationship with Agrisoma, and pursue the potential of Resonance® at a global scale," said Andrew Paterson, CEO of Paterson GlobalFoods Inc. "We have an unwavering commitment to bold innovation and new opportunities. We highly value our relationships, and Resonance® offers farmers crop rotation flexibility, another source of income and a chance to participate in the flourishing bio-energy sector."
"PGF provides a very important link in the biofuel value chain," said Dr. Fabijanski. "Paterson's leadership in the grain handling industry expands our ability to scale Resonance® carinata, and allows us to focus on our core competencies as a seed and technology company."
Resonance® carinata has been specifically developed for production on semi-arid land such as the brown soil zone regions of Western Canada found in southern Saskatchewan and Alberta and other regions. The crop produces oil suited to industrial uses, such as biofuel production, and was the exclusive feedstock for the first 100% biofuel flight flown in October, 2012. The crop is vigorous and hearty, with good resistance to ecosystem stressors. Resonance® carinata showed potential in 2012 by growing well under a variety of conditions that were less than ideal.
About Calyx
Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is an agricultural technology company focused on renewable fuels including biojet and biodiesel. Calyx's majority-owned operating subsidiary, Agrisoma Biosciences Inc., is producing an exciting new proprietary non-food energy feedstock crop, Resonance® carinata, which yields oil that can be refined into fuel which works in existing engines as a 100 percent petroleum substitute. From seed to sky, fuels produced from carinata substantially reduce carbon and other harmful emissions, and help to reduce global petroleum dependence. For further information about Calyx, please visit www.calyxbio.com
Calyx Announces Prominent Climate Change Attorney Appointed as Advisor
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 26, 2013) - Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is pleased to announce the appointment of Gray Taylor, identified in 2011 as the leading climate change lawyer in Canada, as an advisor to the company.
Taylor is presently co-leader and counsel of Bennett Jones' Climate Change and Emission Trading practice. He focuses on climate change and related corporate issues affecting businesses in Canada and abroad. Taylor has acted on a number of complex transactions, including the representation of the largest private sector participants in the World Bank (US) $1-billion Umbrella Carbon Fund transaction.
Taylor is heavily involved with emissions trading transactions involving Emission Reduction Purchase Agreements and related financing and transactional documents for a broad range of Kyoto Protocol (CDM and JI), Alberta and other Canadian regulatory deals. He's also involved with North American and international voluntary carbon deals, and advises on corporate governance and climate change business planning issues.
Past Chair of the National Environmental, Energy and Resources Law Section of the Canadian Bar Association, Taylor is a director of the International Emissions Trading Association and the co-chair of its Canadian Working Group.
"As a leading climate change lawyer, Gray Taylor brings insight and a wealth of experience to our table," said Hugh Notman, President and CEO of Calyx. "His guidance will be very valuable with our majority-owned subsidiary, Agrisoma Biosciences Inc., and its efforts to commercialize its proprietary oilseed crop for biofuel production. His deep understanding of climate change initiatives will be extremely helpful as we create biofuel initiatives and accelerate our company's development."
"It is a privilege to be associated with Calyx and its biofuels business," said Taylor. "Harnessing the ecosystem to reduce greenhouse gas emissions is a critical part of achieving a low-carbon future. I believe Calyx can play an important role in those efforts."
About Calyx
Calyx Bio-Ventures Inc. trades on the TSX Venture Exchange under the symbol "CYX" and owns a majority position in Agrisoma Biosciences Inc. Agrisoma is a private agricultural biotechnology company that uses a proprietary Engineered Trait Loci (ETL) technology licensed from Calyx to commercialize a suite of industry-leading oil quality and crop improvement traits for use in energy feedstock crops. Agrisoma is currently commercializing Resonance™ carinata, a non-food oilseed crop that is well suited for cultivation on semi-arid lands. For further information about Calyx, its technology, collaborations and partnerships, please visit www.calyxbio.com. For more information about Agrisoma, visit www.agrisoma.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact Information:
Calyx Bio-Ventures Inc.
W. Hugh Notman
President & CEO
604-689-2495
hnotman@calyxbio.com
Calyx Bio-Ventures Inc.
Keir Reynolds
Investor Relations
778-998-9242
kreynolds@calyxbio.com
www.calyxbio.com
Pinnacle Digest features Calyx - Our Big Bet of 2013: Calyx Bio-Ventures (CYX:TSXV)
Stock is up 12% With great volume..keep watch for it to break resistance.
Excerpt from the article:
Our new client and Featured Company, Calyx Bio-Ventures (CYX:TSXV), will undoubtedly represent the largest trade we make in 2013. Calyx owns a majority interest in a game changing renewable energy company that was recently a part of aviation history. When it comes to renewable energy investing, a sector with which we have been involved for many years, a company must have what we refer to as the 5 M's: Mission, Mandates, Management, Money and a low Market Cap.
Calyx Bio-Ventures' mission is a remarkable one and that's why we are introducing it to you. The company's operating subsidiary, in partnership with the government of Canada, Chevron Lummus Global and Applied Research Associates, recently made world history in what Popular Science Magazine referred to as one of "The Big Science Stories of 2012".
Read the full article: http://bit.ly/CalyxPinnacle
Followers
|
0
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31
|
Created
|
02/19/13
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |